Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Fasteris is the life science brand of Switzerland-based Genesupport SA and provides DNA and RNA sequencing services for research and medical genetics applications. The company offers next-generation sequencing and Sanger sequencing, including library preparation, extraction, bioinformatics analysis, and customized genomics workflows for academic, industrial, governmental, and private laboratories. Its offerings span DNA sequencing, RNA sequencing, whole exome sequencing, metagenomics, epigenetics, variant detection, and long-read and short-read sequencing workflows. Fasteris operates as a service-based genomics company rather than a therapeutic drug developer, with commercialized sequencing services and laboratory support infrastructure in Switzerland.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Fasteris.